Dynavax Reports Second Quarter 2022 Financial Results

Go back to Dynavax Reports Second Quarter 2022 Financial Results

Dynavax (DVAX) Tops Q2 EPS by 64c

August 4, 2022 4:06 PM EDT

Dynavax (NASDAQ: DVAX) reported Q2 EPS of $0.87, $0.64 better than the analyst estimate of $0.23. Revenue for the quarter came in at $256.5 million versus the consensus estimate of $150.99 million.

GUIDANCE:

2022 Financial GuidanceDynavax anticipates 2022 revenues, operating expenses, and other... More